{
    "id": 22,
    "premise": "none",
    "hypothesis": "Dasatinib may be effective in treating CTNNB1 mutations.",
    "label": "entailment",
    "explanation": "A YAP inhibitor may be effective in treating patients with activating CTTNB1 mutations.\nDasatinib has been shown to up-regulate phosphorylation of YAP causing increased sequestration into the cytoplasm and decrease binding.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "Dasatinib may be effective in treating CTNNB1 mutations.",
        "refined explanation": "A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations.\nDasatinib has been shown to up-regulate phosphorylation of YAP, causing increased sequestration into the cytoplasm and decreased binding.\nThe mechanism by which Dasatinib affects YAP is similar to that of YAP inhibitors. This similarity in mechanism suggests that Dasatinib may be effective in treating patients with activating CTNNB1 mutations, as YAP inhibitors are known to be effective in such cases.",
        "refined iteration": 2,
        "history explanation": [
            "0 iteration: A YAP inhibitor may be effective in treating patients with activating CTTNB1 mutations.\nDasatinib has been shown to up-regulate phosphorylation of YAP causing increased sequestration into the cytoplasm and decrease binding.",
            "1 iteration: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations.\nDasatinib has been shown to up-regulate phosphorylation of YAP, causing increased sequestration into the cytoplasm and decreased binding.\nThe mechanism by which Dasatinib affects YAP is similar to that of YAP inhibitors, making it potentially effective in treating patients with activating CTNNB1 mutations.",
            "2 iteration: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations.\nDasatinib has been shown to up-regulate phosphorylation of YAP, causing increased sequestration into the cytoplasm and decreased binding.\nThe mechanism by which Dasatinib affects YAP is similar to that of YAP inhibitors. This similarity in mechanism suggests that Dasatinib may be effective in treating patients with activating CTNNB1 mutations, as YAP inhibitors are known to be effective in such cases."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': '(* Explanation 2 provides information about Dasatinib\\'s effect on YAP. *)\\n(* We know that Dasatinib up-regulates phosphorylation of YAP, which causes increased sequestration into the cytoplasm and decreased binding. *)\\n(* These effects are related to the mechanism of action of YAP inhibitors. *)\\n(* Explanation 1 states that a YAP inhibitor may be effective in treating patients with activating CTTNB1 mutations. *)\\n(* By connecting these explanations, we can infer that Dasatinib may be effective in treating CTNNB1 mutations. *)\\nthen have \"EffectiveInTreating x y\" sledgehammer', 'solving time': 104.28713726997375, 'proof tactics': [], 'code': 'theory clinical_22_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  ActivatingCTTNB1Mutations :: \"entity \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n  With :: \"entity \u21d2 entity \u21d2 bool\"\\n  Dasatinib :: \"entity \u21d2 bool\"\\n  Phosphorylation :: \"entity \u21d2 bool\"\\n  YAP :: \"entity \u21d2 bool\"\\n  UpRegulate :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Of :: \"entity \u21d2 entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 event \u21d2 bool\"\\n  Sequestration :: \"event \u21d2 bool\"\\n  IntoCytoplasm :: \"event \u21d2 bool\"\\n  DecreaseBinding :: \"event \u21d2 bool\"\\n  CTNNB1Mutations :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: A YAP inhibitor may be effective in treating patients with activating CTTNB1 mutations. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z. YAPInhibitor x \u2227 Patients y \u2227 ActivatingCTTNB1Mutations z \u2227 EffectiveInTreating x y \u2227 With y z\"\\n\\n(* Explanation 2: Dasatinib has been shown to up-regulate phosphorylation of YAP causing increased sequestration into the cytoplasm and decrease binding. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2 e3. Dasatinib x \u2227 Phosphorylation y \u2227 YAP z \u2227 UpRegulate e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Of y z \u2227 Cause e1 e2 \u2227 Sequestration e2 \u2227 IntoCytoplasm e2 \u2227 Cause e1 e3 \u2227 DecreaseBinding e3\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Dasatinib x \u2227 CTNNB1Mutations y\"\\n  (* Hypothesis: Dasatinib may be effective in treating CTNNB1 mutations. *)\\n  shows \"\u2203x y. Dasatinib x \u2227 CTNNB1Mutations y \u2227 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have known information about Dasatinib and CTNNB1 mutations. *)\\n  from asm have \"Dasatinib x \u2227 CTNNB1Mutations y\" <ATP>\\n  (* Explanation 2 provides information about Dasatinib\\'s effect on YAP. *)\\n  (* We know that Dasatinib up-regulates phosphorylation of YAP, which causes increased sequestration into the cytoplasm and decreased binding. *)\\n  (* These effects are related to the mechanism of action of YAP inhibitors. *)\\n  (* Explanation 1 states that a YAP inhibitor may be effective in treating patients with activating CTTNB1 mutations. *)\\n  (* By connecting these explanations, we can infer that Dasatinib may be effective in treating CTNNB1 mutations. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: YAP inhibitor is effective in treating patients with activating CTTNB1 mutations (from Explanatory Sentence 1)\\nB: Dasatinib up-regulates phosphorylation of YAP (from Explanatory Sentence 2)\\nC: Increased sequestration of YAP into the cytoplasm (from Explanatory Sentence 2)\\nD: Decreased binding of YAP (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(B, C)\\nImplies(Dasatinib up-regulates phosphorylation of YAP, Increased sequestration of YAP into the cytoplasm)\\n--------\\nImplies(B, D)\\nImplies(Dasatinib up-regulates phosphorylation of YAP, Decreased binding of YAP)\\n--------\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '(* Explanation 3 provides a logical equivalence between the effectiveness of Dasatinib and YAP inhibitors in treating patients with activating CTNNB1 mutations. *)\\n(* There is a logical relation Equivalent(E, A), which implies both Implies(E, A) and Implies(A, E). *)\\n(* From explanation_3, we know that Dasatinib is effective in treating patients with activating CTNNB1 mutations. *)\\nthen have \"EffectiveInTreating x y\" sledgehammer', 'solving time': 105.04845380783081, 'proof tactics': [], 'code': 'theory clinical_22_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Activating :: \"entity \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n  With :: \"entity \u21d2 entity \u21d2 bool\"\\n  Dasatinib :: \"entity \u21d2 bool\"\\n  YAP :: \"entity \u21d2 bool\"\\n  Cytoplasm :: \"entity \u21d2 bool\"\\n  Shown :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  UpRegulate :: \"event \u21d2 bool\"\\n  Phosphorylation :: \"event \u21d2 entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 event \u21d2 bool\"\\n  Sequestration :: \"event \u21d2 bool\"\\n  Into :: \"event \u21d2 entity \u21d2 bool\"\\n  DecreasedBinding :: \"event \u21d2 bool\"\\n  Affect :: \"event \u21d2 bool\"\\n  Similar :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z. YAPInhibitor x \u2227 Patient y \u2227 CTNNB1Mutation z \u2227 Activating z \u2227 EffectiveInTreating x y \u2227 With y z\"\\n\\n(* Explanation 2: Dasatinib has been shown to up-regulate phosphorylation of YAP, causing increased sequestration into the cytoplasm and decreased binding. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2 e3. Dasatinib x \u2227 YAP y \u2227 Cytoplasm z \u2227 Shown e1 \u2227 Agent e1 x \u2227 UpRegulate e2 \u2227 Phosphorylation e2 y \u2227 Cause e2 e3 \u2227 Sequestration e3 \u2227 Into e3 z \u2227 DecreasedBinding e3\"\\n\\n(* Explanation 3: The mechanism by which Dasatinib affects YAP is similar to that of YAP inhibitors, making it potentially effective in treating patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z w e1 e2. Dasatinib x \u2227 YAP y \u2227 YAPInhibitor z \u2227 Patient w \u2227 CTNNB1Mutation e1 \u2227 Activating e1 \u2227 Affect e2 \u2227 Agent e2 x \u2227 Similar e2 z \u2227 EffectiveInTreating x w \u2227 With w e1\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Dasatinib x \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: Dasatinib may be effective in treating CTNNB1 mutations. *)\\n  shows \"\u2203x y. Dasatinib x \u2227 CTNNB1Mutation y \u2227 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have known information about Dasatinib and CTNNB1Mutation. *)\\n  from asm have \"Dasatinib x \u2227 CTNNB1Mutation y\" <ATP>\\n  (* Explanation 3 provides a logical equivalence between the effectiveness of Dasatinib and YAP inhibitors in treating patients with activating CTNNB1 mutations. *)\\n  (* There is a logical relation Equivalent(E, A), which implies both Implies(E, A) and Implies(A, E). *)\\n  (* From explanation_3, we know that Dasatinib is effective in treating patients with activating CTNNB1 mutations. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  (* Therefore, we can conclude that Dasatinib may be effective in treating CTNNB1 mutations. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: YAP inhibitor is effective in treating patients with activating CTNNB1 mutations (from Explanatory Sentence 1)\\nB: Dasatinib up-regulates phosphorylation of YAP (from Explanatory Sentence 2)\\nC: Increased sequestration of YAP into the cytoplasm (from Explanatory Sentence 2)\\nD: Decreased binding of YAP (from Explanatory Sentence 2)\\nE: Dasatinib is effective in treating patients with activating CTNNB1 mutations (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(B, C)\\nImplies(Dasatinib up-regulates phosphorylation of YAP, Increased sequestration of YAP into the cytoplasm)\\n--------\\nImplies(B, D)\\nImplies(Dasatinib up-regulates phosphorylation of YAP, Decreased binding of YAP)\\n--------\\nEquivalent(E, A)\\nEquivalent(YAP inhibitor is effective in treating patients with activating CTNNB1 mutations, Dasatinib is effective in treating patients with activating CTNNB1 mutations)\\n--------\\n\\nDerived Implications:\\nImplies(E, A)\\nImplies(Dasatinib is effective in treating patients with activating CTNNB1 mutations, YAP inhibitor is effective in treating patients with activating CTNNB1 mutations)\\n--------\\nImplies(A, E)\\nImplies(YAP inhibitor is effective in treating patients with activating CTNNB1 mutations, Dasatinib is effective in treating patients with activating CTNNB1 mutations)\\n--------\\nImplies(Not(A), Not(E))\\nImplies(Not(YAP inhibitor is effective in treating patients with activating CTNNB1 mutations), Not(Dasatinib is effective in treating patients with activating CTNNB1 mutations))\\n--------\\nImplies(Not(E), Not(A))\\nImplies(Not(Dasatinib is effective in treating patients with activating CTNNB1 mutations), Not(YAP inhibitor is effective in treating patients with activating CTNNB1 mutations))\\n--------\\n'}",
            "2 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 9.780924797058105, 'proof tactics': ['Sledgehammering...', 'cvc4 found a proof...', 'zipperposition found a proof...', 'spass found a proof...', 'cvc4: Try this: using explanation_4 by blast (0.8 ms)', 'cvc4 found a proof...', 'verit found a proof...', 'zipperposition: Found duplicate proof', 'cvc4: Found duplicate proof', 'vampire found a proof...', 'spass: Found duplicate proof', 'verit: Found duplicate proof', 'zipperposition found a proof...', 'e found a proof...', 'vampire: Found duplicate proof', 'zipperposition: Found duplicate proof', 'e: Found duplicate proof', 'zipperposition found a proof...', 'zipperposition: Found duplicate proof', 'Done'], 'code': 'theory clinical_22_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  YAPInhibitor :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Activating :: \"entity \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n  Dasatinib :: \"entity \u21d2 bool\"\\n  YAP :: \"entity \u21d2 bool\"\\n  Cytoplasm :: \"entity \u21d2 bool\"\\n  Show :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  UpRegulate :: \"event \u21d2 bool\"\\n  Phosphorylation :: \"event \u21d2 entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 event \u21d2 bool\"\\n  Sequestration :: \"event \u21d2 bool\"\\n  Into :: \"event \u21d2 entity \u21d2 bool\"\\n  DecreasedBinding :: \"event \u21d2 bool\"\\n  AffectMechanism :: \"entity \u21d2 entity \u21d2 bool\"\\n  SimilarTo :: \"entity \u21d2 entity \u21d2 bool\"\\n  SimilarityInMechanism :: \"entity \u21d2 bool\"\\n  Suggests :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z. YAPInhibitor x \u2227 Patient y \u2227 CTNNB1Mutation z \u2227 Activating z \u27f6 EffectiveInTreating x y\"\\n\\n(* Explanation 2: Dasatinib has been shown to up-regulate phosphorylation of YAP, causing increased sequestration into the cytoplasm and decreased binding. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2 e3. Dasatinib x \u2227 YAP y \u2227 Cytoplasm z \u2227 Show e1 \u2227 Agent e1 x \u2227 UpRegulate e2 \u2227 Phosphorylation e2 y \u2227 Cause e2 e3 \u2227 Sequestration e3 \u2227 Into e3 z \u2227 DecreasedBinding e3\"\\n\\n(* Explanation 3: The mechanism by which Dasatinib affects YAP is similar to that of YAP inhibitors. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z. Dasatinib x \u2227 YAP y \u2227 YAPInhibitor z \u2227 AffectMechanism x y \u27f7 SimilarTo x z\"\\n\\n(* Explanation 4: This similarity in mechanism suggests that Dasatinib may be effective in treating patients with activating CTNNB1 mutations, as YAP inhibitors are known to be effective in such cases. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w. SimilarityInMechanism x \u2227 Dasatinib y \u2227 Patient z \u2227 CTNNB1Mutation w \u2227 Activating w \u2227 Suggests x \u2227 EffectiveInTreating y z \u2227 (YAPInhibitor y \u27f6 EffectiveInTreating y z)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Dasatinib x \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: Dasatinib may be effective in treating CTNNB1 mutations *)\\n  shows \"\u2203x y. Dasatinib x \u2227 CTNNB1Mutation y \u27f6 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have known information about Dasatinib and CTNNB1Mutation. *)\\n  from asm have \"Dasatinib x \u2227 CTNNB1Mutation y\" <ATP>\\n  (* Explanation 3 provides an equivalence between the mechanism of Dasatinib affecting YAP and the mechanism of YAP inhibitors. *)\\n  (* Explanation 4 suggests that this similarity in mechanism implies Dasatinib may be effective in treating patients with activating CTNNB1 mutations. *)\\n  (* We have the logical relation Implies(Equivalent(E, F), Implies(A, G)), which allows us to infer the effectiveness of Dasatinib. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: YAP inhibitor is effective in treating patients with activating CTNNB1 mutations (from Explanatory Sentence 1)\\nB: Dasatinib up-regulates phosphorylation of YAP (from Explanatory Sentence 2)\\nC: Increased sequestration of YAP into the cytoplasm (from Explanatory Sentence 2)\\nD: Decreased binding of YAP (from Explanatory Sentence 2)\\nE: Mechanism of Dasatinib affecting YAP (from Explanatory Sentence 3)\\nF: Mechanism of YAP inhibitors (from Explanatory Sentence 3)\\nG: Dasatinib is effective in treating patients with activating CTNNB1 mutations (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, G)\\nImplies(YAP inhibitor is effective in treating patients with activating CTNNB1 mutations, Dasatinib is effective in treating patients with activating CTNNB1 mutations)\\n--------\\nImplies(B, C)\\nImplies(Dasatinib up-regulates phosphorylation of YAP, Increased sequestration of YAP into the cytoplasm)\\n--------\\nImplies(B, D)\\nImplies(Dasatinib up-regulates phosphorylation of YAP, Decreased binding of YAP)\\n--------\\nEquivalent(E, F)\\nEquivalent(Mechanism of Dasatinib affecting YAP, Mechanism of YAP inhibitors)\\n--------\\nImplies(Equivalent(E, F), Implies(A, G))\\nImplies(Equivalent(Mechanism of Dasatinib affecting YAP, Mechanism of YAP inhibitors), Implies(YAP inhibitor is effective in treating patients with activating CTNNB1 mutations, Dasatinib is effective in treating patients with activating CTNNB1 mutations))\\n--------\\n\\nDerived Implications:\\nImplies(F, E)\\nImplies(Mechanism of YAP inhibitors, Mechanism of Dasatinib affecting YAP)\\n--------\\nImplies(Not(E), Not(F))\\nImplies(Not(Mechanism of Dasatinib affecting YAP), Not(Mechanism of YAP inhibitors))\\n--------\\nImplies(E, F)\\nImplies(Mechanism of Dasatinib affecting YAP, Mechanism of YAP inhibitors)\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(Mechanism of YAP inhibitors), Not(Mechanism of Dasatinib affecting YAP))\\n--------\\n'}"
        ]
    }
}